Transgenomic Closes Bridge Financing

/in , , , /by

Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC, which is expected to […]

Read more →

Xylem increases its 2020 financial targets and reaffirms its strategy to reflect accelerated growth driven by acquisitions

/in /by

Company also reaffirms full-year 2017 guidance RYE BROOK, N.Y.—- At its Investor Day in Raleigh-Durham, North Carolina, Xylem (NYSE:XYL), a leading global water technology company, today will update its 2020 financial guidance and showcase the broad portfolio of smart infrastructure technologies and solutions provided by its Sensus and Visenti businesses. Xylem acquired Sensus and Visenti in October 2016. Xylem […]

Read more →

Xylem increases its 2020 financial targets and reaffirms its strategy to reflect accelerated growth driven by acquisitions

/in /by

Company also reaffirms full-year 2017 guidance RYE BROOK, N.Y.–(BUSINESS WIRE)– At its Investor Day in Raleigh-Durham, North Carolina, Xylem (NYSE:XYL), a leading global water technology company, today will update its 2020 financial guidance and showcase the broad portfolio of smart infrastructure technologies and solutions provided by its Sensus and Visenti businesses. Xylem acquired Sensus and Visenti in October 2016. […]

Read more →

Echo Raises $7.5 Million in Funding for Manufacturing and Product Expansion

/in , /by

SAN DIEGO Echo, the company who created the first-ever hybrid microscope, announced today the completion of $7.5 million in Series A funding. The capital investment, co-led by Dolby Family Ventures and Tech Coast Angels (TCA), will support Echo in scaling manufacturing, strengthening the company’s sales infrastructure, and developing future technologies. Echo, formerly Echo Laboratories, is […]

Read more →

Cytek Biosciences Poised to Accelerate Flow Cytometry Adoption

/in , /by

FREMONT, CA— Early detection and diagnosis can greatly increase the chances of successful treatment of diseases. Flow cytometry puts time on the side of researchers and clinicians by giving them the ability to quickly analyze multiple characteristics of single cells simultaneously. Life science researchers know this, yet adoption of this technology has lagged. Cytek Biosciences […]

Read more →

Twist Bioscience Raises $33 Million

/in , /by

SAN FRANCISCO — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it raised an additional $33 million. To date, Twist Bioscience has raised a total of $166 million. “It is an exciting time to be leading Twist Bioscience as we expand our reach and continue to deliver industry-leading gene […]

Read more →

Sygnis announces change in guarantee for Spanish government soft loans

/in , /by

Share loan from Dr. Heikki Lanckriet guarantees government soft loans Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS, will guarantee soft loans from the Spanish government with 500,000 of his SYGNIS shares. The guarantee secures the EUR 1.9 […]

Read more →

Merck Accelerator hits new peak of applications

/in , /by

Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany and Nairobi, Kenya. The two program locations accept startups from different fields within Merck’s core specialisms: Darmstadt takes startups from the fields of healthcare, life sciences and performance materials, while Nairobi works exclusively on innovations […]

Read more →